Thomas Striepe
Chief Executive Officer bij SANGUI BIOTECH INTERNATIONAL, INC.
Profiel
Thomas Striepe is currently the President, CEO, CFO & Director at Sangui BioTech International, Inc. He is also the Vice President-Finance & Controlling at Dr. Ludz Vermögensberatungs & Vermittlungs GmbH and the Vice President-Accounting & Controller at Treukonzept Finance GmbH.
Previously, he worked as the CFO, Head-Investor & Press Relations at Feedback AG.
Mr. Striepe holds an MBA from the University of Hamburg.
Actieve functies van Thomas Striepe
| Bedrijven | Functie | Begin |
|---|---|---|
| SANGUI BIOTECH INTERNATIONAL, INC. | Chief Executive Officer | 07-02-2005 |
| Dr. Ludz Vermögensberatungs & Vermittlungs GmbH | Director of Finance/CFO | 01-01-2004 |
| Treukonzept Finance GmbH | Comptroller/Controller/Auditor | 01-01-2004 |
Eerdere bekende functies van Thomas Striepe
| Bedrijven | Functie | Einde |
|---|---|---|
| FEEDBACK AG | Director of Finance/CFO | - |
Opleiding van Thomas Striepe
| University of Hamburg | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SANGUI BIOTECH INTERNATIONAL, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Feedback AG
 Feedback AG Financial ConglomeratesFinance Feedback AG is a holding company, which engages in the provision of financial and consulting services to institutional and private clients. It specializes in the development, analysis and placement of closed-end funds. Feedback also offers consulting and support services in the area of return-oriented investments. The company was founded on October 29, 1996 and is headquartered in Hamburg, Germany. | Finance |
| Dr. Ludz Vermögensberatungs & Vermittlungs GmbH | |
| Treukonzept Finance GmbH |
